Sign in
Taking people in United StatesNo phase

Looking for undiagnosed primary ciliary dyskinesia in adults with bronchiectasis

Checks how often primary ciliary dyskinesia goes undiagnosed in adults with bronchiectasis.

Key facts

Who runs it
Indiana University
Where
Indianapolis, United StatesSee the site
Trial code
Registry title
Primary Ciliary Dyskinesia in Adult Bronchiectasis
Status
Recruiting
People taking part
60 people, planned
Started
17 Jul 2026
Expected to end
31 Jan 2028
Type of study
Interventional
Treatments tested
  • Nasal Nitric Oxide Measurement
  • Nasopharyngeal (Nasal) Samples
Record updated
12 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with bronchiectasis (widened, damaged airways in the lungs). It checks how often primary ciliary dyskinesia (PCD) is present but not yet diagnosed.

Age
18 years and older
Sex
All sexes can join.
Disease stage
Bronchiectasis confirmed on a CT scan. People with a known or new diagnosis can join.

Main reasons for not taking part

  • Already diagnosed with cystic fibrosis
  • Already diagnosed with primary ciliary dyskinesia
  • Not able to do the tests
  • Not giving consent

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Adults (≥18) with CT-confirmed bronchiectasis

Who cannot take part

  • Pre-existing diagnosis of cystic fibrosis
  • Pre-existing diagnosis of primary ciliary dyskinesia
  • Inability to perform testing
  • Refusal of consent

Where in United States

  • Riley Hospital for ChildrenIndianapolis, United StatesContact: Kenzie MahanTaking people

About the trial

What the trial wants to find out

The purpose of this study is to help determine how often primary ciliary dyskinesia (PCD) is present but undiagnosed in adults with bronchiectasis.

The group in the trial

  • BronchiectasisTreatment being tested

    patients with a known or new diagnosis of bronchiectasis

    Treatment: Nasal Nitric Oxide Measurement and Nasopharyngeal (Nasal) Samples

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Novel Use of Combined High-Speed Video Microscopy and Nasal Nitric Oxide Screening for Identification of Primary Ciliary Dyskinesia in Adult Bronchiectasis
Plain-language title
Looking for undiagnosed primary ciliary dyskinesia in adults with bronchiectasisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 August 2026